日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gut Microbial Communities Are Seasonally Variable in Warm-Climate Lizards Hibernating in the Winter Months

温暖气候蜥蜴在冬季冬眠期间,其肠道微生物群落会随季节变化。

Zhu, Xiaming; Jiang, Neng; Mai, Tingye; Wu, Shulin; Yao, Yuntao; Du, Yu; Lin, Chixian; Lin, Longhui; Ji, Xiang

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

更正为:针对 DHODH 的新型强效抑制剂是针对 RNA 病毒(包括新出现的冠状病毒 SARS-CoV-2)的广谱抗病毒药物

Rui Xiong #, Leike Zhang #, Shiliang Li #, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillete, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, Honglin Li, Ke Xu

Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses

原卟啉广谱抗病毒药物可抑制高致病性新发病毒的入侵

Shengsheng Lu, Xiaoyan Pan, Daiwei Chen, Xi Xie, Yan Wu, Weijuan Shang, Xiaming Jiang, Yuan Sun, Sheng Fan, Jian He

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

针对 DHODH 的新型强效抑制剂是针对 RNA 病毒(包括新出现的冠状病毒 SARS-CoV-2)的广谱抗病毒药物

Rui Xiong #, Leike Zhang #, Shiliang Li #, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillete, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, Honglin Li, Ke Xu

Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension

钙通道阻滞剂苯磺酸氨氯地平治疗与伴有高血压的 COVID-19 患者的病死率降低相关

Lei-Ke Zhang #, Yuan Sun #, Haolong Zeng #, Qingxing Wang #, Xiaming Jiang, Wei-Juan Shang, Yan Wu, Shufen Li, Yu-Lan Zhang, Zhao-Nian Hao, Hongbo Chen, Runming Jin, Wei Liu, Hao Li, Ke Peng, Gengfu Xiao

Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro

病毒蛋白酶抑制剂对新型 SARS-CoV-2 的体外抗病毒效果比较

Leike Zhang #, Jia Liu #, Ruiyuan Cao #, Mingyue Xu, Yan Wu, Weijuan Shang, Xi Wang, Huanyu Zhang, Xiaming Jiang, Yuan Sun, Hengrui Hu, Yufeng Li, Gang Zou, Min Zhang, Lei Zhao, Wei Li, Xiaojia Guo, Xiaomei Zhuang, Xing-Lou Yang, Zheng-Li Shi, Fei Deng, Zhihong Hu, Gengfu Xiao, Manli Wang, Wu Zhong